AAAAAA
Results:
1-7
|
Results: 7
Authors:
RUSHING DA
Citation: Da. Rushing, HIGH-DOSE CHEMOTHERAPY FOR BREAST-CANCER, Annals of internal medicine, 126(11), 1997, pp. 917-917
Authors:
RUSHING DA
RABER SR
RODVOLD KA
PISCITELLI SC
FLANK GS
TEWKSBURY DA
Citation: Da. Rushing et al., THE EFFECTS OF CYCLOSPORINE ON THE PHARMACOKINETICS OF DOXORUBICIN INPATIENTS WITH SMALL-CELL LUNG-CANCER - REPLY, Cancer, 75(5), 1995, pp. 1215-1216
Authors:
RABER SR
RUSHING DA
RODVOLD KA
PISCITELLI SC
PLANK GS
TEWKSBURY DA
Citation: Sr. Raber et al., EFFECTS OF CYCLOSPORINE (CSA) ON PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF DOXORUBICIN (DOX), Clinical pharmacology and therapeutics, 55(2), 1994, pp. 189-189
Authors:
RUSHING DA
RABER SR
RODVOLD KA
PISCITELLI SC
PLANK GS
TEWKSBURY DA
Citation: Da. Rushing et al., THE EFFECTS OF CYCLOSPORINE ON THE PHARMACOKINETICS OF DOXORUBICIN INPATIENTS WITH SMALL-CELL LUNG-CANCER, Cancer, 74(3), 1994, pp. 834-841
Authors:
RUSHING DA
SMITH S
CUSIC M
Citation: Da. Rushing et al., APNEA AFTER ETOPOSIDE, Lancet, 341(8856), 1993, pp. 1353-1354
Authors:
RUSHING DA
PISCITELLI SC
RODVOLD KA
TEWKSBURY DA
Citation: Da. Rushing et al., THE DISPOSITION OF DOXORUBICIN ON REPEATED DOSING, Journal of clinical pharmacology, 33(8), 1993, pp. 698-702
Authors:
PISCITELLI SC
RODVOLD KA
RUSHING DA
TEWKSBURY DA
Citation: Sc. Piscitelli et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF DOXORUBICIN IN PATIENTS WITHSMALL-CELL LUNG-CANCER, Clinical pharmacology and therapeutics, 53(5), 1993, pp. 555-561
Risultati:
1-7
|